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AbstrACt
Objectives Respiratory tract infections are frequently 
managed by nurse and pharmacist prescribers, and 
these prescribers are responsible for 8% of all primary 
care antibiotic prescriptions. Few studies have explored 
antibiotic prescribing among these prescribers, and 
interventions to target their antibiotic prescribing 
behaviour do not exist. Research objectives were to: (1) 
use the Theoretical Domains Framework to identify the 
factors that influence nurse and pharmacist prescriber 
management of respiratory tract infections and (2) identify 
the behaviour change techniques (BCTs) that can be 
used as the basis for the development of a theoretically 
informed intervention to support appropriate prescribing 
behaviour.
Design Qualitative design comprising semistructured 
interviews, using the Theoretical Domains Framework and 
Capability, Opportunity and Motivation for Behaviour.
setting Primary care.
Participants Twenty one prescribers (4 pharmacists and 
17 nurses).
results A range of factors across 12 domains of the TDF 
were found to influence prescriber behaviour, and 40 BCTs 
were identified as supporting appropriate prescribing. 
For example, patient expectations (social influence) was 
identified as a factor influencing prescribing decisions, 
and a number of BCTs (problem solving, goal setting and 
information about health consequences) were identified as 
supporting prescribers in managing these expectations.
Conclusion With increasing numbers of nurse and 
pharmacist prescribers managing infections in primary 
care, these findings will inform theoretically grounded 
interventions to support appropriate prescribing behaviour 
by these groups.
IntrODuCtIOn
Multidrug-resistant infections are one of the 
greatest threats to human health,1 respon-
sible for an estimated 25 000 deaths and 
€1.5 billion in extra healthcare costs every year 
in the European Union alone.2 Between 2000 
and 2010, the global human consumption of 
antibiotics increased by 36%.3 The inappro-
priate use of antimicrobials in humans, is a 
leading driver for the increase in antimicro-
bial resistance (AMR)4; however, resistance is 
reversible,5 and strategies that support appro-
priate antibiotic use are crucial.6 
Most antibiotics are prescribed in primary 
care for respiratory tract infections (RTIs)7–9; 
however, most RTIs spontaneously resolve 
without an antibiotic. Conserving antibiotic 
sensitivity through the management of RTIs 
without recourse to antibiotics is a global 
priority,5 7 10 11 and the antibiotic prescribing 
behaviour of healthcare professionals is a key 
target for intervention.
Existing research has focused on under-
standing how general practitioners (GPs) 
make prescribing decisions for patients with 
acute RTIs. Key influences include percep-
tions of patient expectations,12 patient 
pressure,13 diagnostic uncertainty,14 factors 
imposed by healthcare systems and clinician 
characteristics.15 Systematic reviews16 17 have 
strengths and limitations of this study
 ► Using an established framework to explore the the-
oretical mechanisms of action and mechanisms of 
change to understand the antibiotic prescribing be-
haviour of nurse and pharmacist prescribers is a key 
strength.
 ► Although participants were a national sample, few 
were pharmacists and so our findings may not pres-
ent an accurate picture of this population; however, 
this sample reflects UK primary care where most 
prescribers are nurses.
 ► Although data saturation was achieved, participants 
were an opportunistic sample and may have been 
more motivated towards appropriate antibiotic 
prescribing.
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identified that effective interventions are those that target 
the broader patient population, are complex and multi-
faceted in addressing barriers to change in specific health-
care settings. Multifaceted interventions that promote 
shared decision making18 have also had promising results.
In the UK, around 30 000 nurses and 4000 pharma-
cists have the same independent prescribing capability as 
doctors.19 The numbers of these ‘non-medical prescribers 
(NMPs)’ is steadily increasing19 to fulfil the workforce 
needs of the National Health Service (NHS).20–22 These 
prescribers frequently manage patients with RTIs and are 
responsible for 8% of all primary care antibiotic prescrip-
tions15; however, few studies have explored their antibiotic 
prescribing practices. Like GPs, diagnostic ambiguity and 
patient expectations can influence decision making.23 
Furthermore, NMPs perceive themselves to be open 
to scrutiny by medical prescribers and are conscious of 
keeping to clinical guidelines.23 Although NMPs have 
developed strategies for managing RTI consultations, 
there is scope for improvement.24
Interventions must be tailored to the population 
and context in which the target behaviours are deliv-
ered.25 26 Although interventions exist to support the anti-
microbial stewardship (AMS) activities in which NMPs are 
involved,27 no interventions exist to target their antibiotic 
prescribing behaviour.
Growing evidence supports the use of theory to iden-
tify barriers and facilitators to changing practitioner 
behaviour.17 28 One such approach is the Behaviour 
Change Wheel (BCW).26 The original BCW encompasses 
three layers that should be considered when supporting 
behaviour change: (1) the determinants of behaviour 
(Capability, Opportunity and Motivation for Behaviour 
(COM)-B); (2) intervention functions with which to 
intervene with these determinants; and (3) policy catego-
ries to support change on a more structural level. At the 
hub of the BCW, the COM-B model aims to facilitate a 
behavioural diagnosis by understanding the determinants 
of behaviour, highlighting an individual’s capability, both 
physical (such as skills) and psychological (such as knowl-
edge); their opportunity, both social (norms of practice) 
and physical (time/space); and motivation, both reflec-
tive (influenced by beliefs such as confidence and inten-
tion) and automatic (influenced by emotion or habit). 
This model is helpful when developing an intervention, 
as it can be easily mapped to an Intervention function 
(ie, education, training and enablement) using the 
table in Michie et al.29 The Theoretical Domains Frame-
work (TDF)30 unpacks the COM-B further, as it sepa-
rates psychosocial drivers of behaviour into 14 domains 
covering a spectrum of theoretical determinants (knowl-
edge, memory, skills and identity). This helps separate 
potential ambiguity when attempting to contextualise 
the determinants of COM-B, that is, a psychological capa-
bility barrier could be both a lack of knowledge or poor 
memory, each of which would require a different Inter-
vention function, for example, education to increase 
knowledge or enablement to enhance memory, and in 
turn different behaviour change techniques (BCTs), for 
example, giving information to increase knowledge, using 
prompts and cues to enhance memory. As this science has 
developed, the TDF has been conceptualised as an addi-
tional layer to the BCW after the COM-B28 31 and COM-B 
has been mapped to the TDF26 and a selection of BCTs 
from the BCT Taxonomy Version 132 that can be selected 
as intervention components to change behaviour.28
However, there is another way to identify and code 
BCTs related to the facilitators of behaviour that lacks 
empirical evidence. Qualitative exploration allows for 
both an in-depth COM-B/TDF behavioural diagnosis and 
the identification of naturally occurring BCTs used by the 
target population when the target behaviour is facilitated.
Objectives
 ► To use a theoretical framework to identify the factors 
that influence management of RTIs.
 ► To identify BCTs that can be used as the basis for the 
development of a theoretically informed intervention 
to support appropriate prescribing behaviour.
MethODs
Design
A qualitative approach using semistructured interviews.
recruitment of participants
NMPs work in a variety of roles in primary care across a 
range of settings.33 34 The uptake of prescribing among 
these healthcare professionals is inconsistent across 
organisations33 34 and not all of these professionals 
manage RTIs. Therefore, an opportunistic sample 
of primary care nurse and pharmacist-independent 
prescribers, responsible for managing patients with RTIs, 
were recruited nationally. Recruitment occurred through 
the Royal College of Nursing General Practice (RCNGP) 
Nurse Forum (approximately 6000 members), the Royal 
Pharmaceutical Society (RPS) Pharmacist Prescribing 
Discussion Group (783 members), Prescribing and Medi-
cines Management Discussion Group (520 members), 
Pharmacists working in GP practices Discussion Group 
(531 members) and the Queens Nurse Network (1200 
members).
Messages were placed on the RCNGP Nurse Forum and 
the three RPS Pharmacist Prescribing Discussion Groups, 
describing the study and inviting eligible participants to 
contact the researchers. Details of the study were emailed 
to members of the Queens Nurse Network by the director 
of programmes. It is not known how many nurses and 
pharmacists across the forums, discussion groups and 
network are qualified prescribers or how many manage 
RTIs. Thirty-one prescribers expressed an interest to take 
part, and 21 (4 pharmacists and 17 nurses) consented to 
participate.
Materials
An interview schedule was developed based on the TDF (see 
table 1). This was a guide, and the interviewer was respon-
sive to answers from interviewees. The TDF, as opposed to 
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the simpler COM-B, allowed a more detailed investigation 
of behavioural determinants.
Procedure
Prescribers who had expressed interest in the study were 
emailed a participant information sheet and a consent 
form. They were able to ask any questions prior to providing 
consent before their interview. Semistructured telephone 
interviews were conducted by an experienced qualitative 
researcher (TC) and were audio-recorded and transcribed 
verbatim. Data collection was between June and July 2017. 
Mean interview time was 45 min (range 25–65 min).
Data analysis
Taking an inductive approach and drawing from thematic 
analysis,35 two researchers (TC/MC) independently coded 
the transcripts using NVivo data management software. 
Initial codes and emerging themes were reviewed with a third 
qualitative researcher (SR). Saturation was achieved (later 
interview data were categorised within the coding frame 
with no new codes). In line with healthcare research that has 
used the TDF and COM-B in interviews with practitioners 
in general practice,36 the third researcher then deductively 
mapped codes to the appropriate ‘domains’ within the TDF 
with ongoing discussion with MC. All codes were mapped 
onto at least one domain. A further qualitative researcher 
with expertise in the BCW (AC), then checked and agreed 
initial codes and their relevance to each TDF domain. Using 
the Behaviour Change Techniques Taxonomy (BCTT) 
v1,32 quotes were then coded by AC for the BCTs that the 
population had described when discussing what influences 
their behaviour and subsequently checked by SR and MC. 
A member checking exercise was considered but deemed 
unnecessary as the approach was deductive and required 
coding according to the TDF and BCT taxonomy.
Patient and public involvement
Patients were not involved in the development of the 
research question, outcome measures, design of the study 
or, recruitment to, and conduct of, the study.
Table 1 Interview schedule and questions under each theoretical domain
Theoretical domain Interview questions
Knowledge  ► What do you know about the use of antibiotics for self-limiting RTIs?
 ► What knowledge do you draw on when managing patients with RTIs?
Skills  ► What skills do you think are needed/helpful in managing these consultations?
 ► If you have decided not to prescribe an antibiotic, what skills are needed to help manage that 
consultation?
Social/professional role  ► What do you think is your role in reducing antibiotic use and antimicrobial resistance?
 ► To what extent do you see this as part of your job?
 ► What is the role of other practitioners in reducing antibiotic use and antimicrobial resistance?
Beliefs about capabilities  ► How confident do you feel that you are able to manage RTI consultations?
 ► How confident do you feel in making decisions about whether to prescribe antibiotics?
 ► What if you are unsure about a diagnosis?
Optimism  ► How confident are you that your consultations with patients with RTIs will have a positive outcome?
 ► How is this affected by whether an antibiotic is prescribed?
Beliefs about consequences  ► What factors influence your decision to prescribe antibiotics?
 ► What are the benefits and risks of not prescribing antibiotics for RTIs?
Goals  ► What are your goals when managing patients within RTI consultations?
Reinforcement  ► What factors may reinforce your decision to prescribe not to prescribe antibiotics?
 ► What factors hinder this decision process?
Intentions  ► What motivates you to prescribe or not?
Memory/attention/decision 
process
 ► How do you decide whether or not to prescribe an antibiotic to someone presenting with RTI?
 ► What processes do you usually follow when managing patients with RTIs?
Environmental context and 
resources
 ► What factors support or hinder you to manage these consultations (eg, practice setting, community 
factors and available resources)?
 ► How do systems in place support you to prescribe appropriately?
Social influences  ► How do patients influence the way you manage RTI consultations and whether you prescribe antibiotics?
 ► How do the people you work with influence your management of RTIs and your decisions around whether 
to prescribe antibiotics?
 ► How do you think you compare with other prescribers in terms of antibiotic prescribing for RTIs?
Emotion  ► How do consultations with patients with RTIs make you feel?
 ► Are there consultations that feel more difficult or uncomfortable?
 ► How do your feelings at the time (mood, feelings towards the patient, fatigue) affect whether or not you 
prescribe antibiotics?
Behavioural regulation  ► What things could support you to manage RTI consultations more satisfactorily for you and the patient?
 ► How do you ensure that your antibiotic prescribing is appropriate to the situation?
 ► What things support you to make decisions about antibiotic prescribing?
RTI, respiratory tract infection.
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results
Participants
Twenty-one prescribers (4 pharmacists and 17 nurses), 
with between 1 year and 17 years’ prescribing experi-
ence (mean 8.5 years, SD 3.7) and between 2.5–32 years’ 
experience in their current role (mean 11 years, SD 8.5) 
took part in interviews. Most worked in general practice, 
had 15 min consultations and reported seeing around 25 
patients a week with RTIs (see table 2).
Factors influencing the management of rtIs
Twenty-six codes were inductively assigned to the data 
from the interview transcripts. Codes were then mapped 
to the TDF domains, whereby 12 domains were iden-
tified as factors that influence appropriate antibiotic 
prescribing. TDF domains were then mapped onto the 
COM-B model to enable future intervention design (see 
online supplementary table 1).
The section below describes how data align within the 
TDF domains. Interview quotes are followed by letters 
and numbers in brackets that indicate the interviewee 
number (I=interviewee, n=nurse, P=pharmacist).
Knowledge (Psychological capability)
Influences on antibiotic prescribing included knowledge 
of current prescribing guidelines and AMS practices 
(with training mechanisms in place to facilitate this) and 
knowledge of AMR and its consequences at an individual 
and a population level. Awareness of own prescribing rate 
compared with other prescribers and national prescribing 
levels was another important influence.
… [W]e have a training session, like an audit with 
the local CCG [clinical commissioning group] team, 
in relation to our practices antibiotic prescribing and 
comparing it to the area in the north west… so that 
Table 2 Demographic details
Interviewee Role
Time 
qualified in 
current role
Time 
qualified as 
a prescriber Clinical setting
No. of RTIs consultations a 
week
Length of 
appointment
(min)
1 Nurse practitioner 11 7 Out-of-hours walk-in 
service.
25 in summer months but 
many more in winter.
15
2 Advanced nurse 
practitioner
5 5 General practice. 20 summer months and 40 
winter months.
15
3 Advanced
nurse practitioner
14 8 General practice. 75 in the winter 30 in summer. 15
4 Advanced nurse 
practitioner
2.5 17 General practice. 25 10
5 Advanced nurse 
practitioner
24 14 Intermediate care (keep 
patients out of hospital).
25 in the summer more in 
winter.
30–45
6 Lead nurse in a general 
practice walk-in centre
7 7 Walk-in centre. 30 15
7 Pharmacist 2 General practice. 20 15
8 Advanced nurse 
practitioner
16 10 General practice. 16–20 15
9 Advanced nurse 
practitioner
3 1 General practice. 30 15
10 Nurse 32 3 Intermediate care (keep 
patients out of hospital).
(missing data). 30–120
11 Advanced nurse 
practitioner
6 7 General practice and out-of-
hours service.
50 15
12 Advanced nurse 
practitioner
4 6 General practice. 40 15
13 Advanced nurse 
practitioner
11 11 (missing data) Several a day. 2 hours
14 Clinical pharmacist 3 10 General practice. 16–20 15
15 Advanced nurse 
practitioner
7 13 General practice. 20–50 10–15
16 General practice nurse 10 8 General practice. 25 15
17 Nurse 25 10 Out-of-hours unscheduled 
care.
1–6 20
18 Lead practice nurse 4 11 General practice. 10 15
19 Lead nurse 18 10 General practice. 30 15–20
20 Pharmacist 11 6 General practice. 25 15
21 Pharmacist 24 6 General practice. Varied 20
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kind of helped influence and perhaps reduced my 
antibiotic prescribing. (I13N)
Memory, attention and decision processes (psychological 
capability)
Treatment decisions were made by weighing up informa-
tion from guidelines, patient pre-existing conditions, and 
illnesses present within the local community, and a full 
examination and point of care testing if appropriate.
If we have decided that they do have an acute bac-
terial (infection) that would benefit from antimi-
crobial treatments, I would use the HPA guidelines, 
un-amended. So we follow the guidelines that are the 
national ones, and depending on the patient’s situa-
tion because of the allergies, co-existing conditions, 
previous treatment perhaps, knowledge of locally cir-
culating bugs, and I would choose according to that. 
(I13N)
Behavioural regulation (psychological capability)
Awareness of antibiotic prescribing rate in relation to 
colleagues and ability to self-regulate behaviour influ-
enced prescribing practice as described above. Self-au-
diting of prescribing practice was also viewed as valuable.
I am happy about that, because that is all about audit-
ing your own practice and doing things like that yes. 
I mean I do go through periods where I audit people 
that I see, what’s happened, did they come back, did 
they get better, did they get worse, and that also kind 
of reassures you as well that you are either doing the 
right or the wrong thing…(I3N)
Skills (physical capability)
A range of skills were described as those required to 
manage the consultation, including physical examination 
and communication skills.
Typically, the clinical examination would start with 
sats, move on to lymph’s, then we would go to throat, 
we go to ear examination if it was indicated, then po-
tentially shirt off, and we would do respiratory signs 
front and back oscultation, percussion… shirt back 
on, summary of assessments, patient’s point of view, 
consider treatments or safety netting, whether it be 
immediate treatment or whether it be standby treat-
ments or it would be no you have got a viral infection 
here, so we go through the signs and what to look out 
for. And then …. make sure that they knew what to 
do if things were to go badly, and when to seek review. 
(I17N)
Competence in these skills, acquired through practice, 
was viewed as important
… [Y]ou have to be competent, not only with your 
history taking… But, examination skills; you have to 
be able to examine… The patient; you have to be able 
to relate those findings… to the patient in a language 
that they can understand. (I15N)
Social/professional role and identity (reflective motivation)
Elements of the NMP role (ie, time to talk to patients, 
being up to date with guidelines and the stringency of 
prescribing rules) supported appropriate antibiotic 
prescribing. Participants saw themselves as personally and 
professionally responsible for appropriate prescribing. 
Several highlighted their role as antibiotic guardians 
(ie, taken a pledge to prescribe responsibly) to manage 
patient expectation.
… [S]o I’ve got that responsibility to the health ser-
vice and to society, and that partly comes with the 
privilege of being a prescriber… I think this is defi-
nitely part of my role. (I17N)
Beliefs about capabilities (reflective motivation)
Newly qualified prescribers reported how a lack of confi-
dence meant advice from more senior colleagues could 
negatively influence prescribing decisions, while others 
indicated they were confident, recognising the limits of 
their role.
… [T]here is one drug that you used to prescribe for 
chest infections and it was always for 7 days and the 
guidelines now are actually for 5 days, and now I al-
ways check my guide … and now I am more confident 
to say no actually it should only be five but when I very 
first started prescribing I found that really difficult …
because I felt maybe I should be prescribing longer 
than it says on the guide, because more experienced 
people are telling me that, so I think when you are 
a newly qualified prescriber, the more experienced 
people can have a strong influence over you and it is 
not always right. (I10N)
Beliefs about consequences (reflective motivation)
Prescribers described ‘managing risk’ by being cautious 
about withholding antibiotics when managing patients at 
risk of developing complications, for example, children, 
elderly patients or those with pre-existing conditions, 
alongside those where there was diagnostic uncertainty 
due to a language barrier. In these cases, they were more 
likely to prescribe antibiotics.
I may treat someone who is very frail, but I wouldn’t 
treat someone who is well… simply because the con-
sequences of not treating would be more serious, 
with the risk of hospitalisation. So I am talking about 
a threshold prescribing, and I think I do adjust that 
threshold according to the individual… based on 
their risk. (I10N)
The consequences of antibiotic use, at an individual 
and population levels, influenced prescribing deci-
sions. Prescribers believed that prescribing antibiotics 
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unnecessarily reinforced patients’ beliefs they were 
the appropriate treatment and influenced future 
expectations.
Some GP’s will just write a prescription for 7 days with 
250 mg of amoxicillin, three times a day. And it’s a 
homeopathic dose it’s a pat on the head and a piece 
of green paper, and the patient comes away from that 
consultation happy, they have got their antibiotics, 
they won’t get better because of the antibiotics, they 
will get better because it is self-limiting, viral RTI. But 
what that health care professional is doing, is perpet-
uating the expectation of I am unwell, I will get an-
tibiotics I will get better. The hard thing you have to 
do as a prescriber is to turn around and say you don’t 
need antibiotics at this time. (I11N)
Fear of a complaint as a consequence of not prescribing 
sometimes influenced prescribing decisions and some 
reported prescribing antibiotics in some cases because 
patients would just reconsult if they were not given them.
Goals (automatic motivation)
Prescribing at an appropriate rate was a key goal for some 
prescribers. Audit and benchmarking practices were 
motivators to reduce prescribing, introducing competi-
tion to be the prescriber with the lowest rate.
I am someone with lower antibiotic prescribing rates 
however, I only work part time. I wouldn’t want my 
data to be high as this would look really bad amongst 
colleagues. (I16N)
Reinforcement (automatic motivation)
Rewards were used by management teams to reinforce 
appropriate prescribing behaviour for example in the 
prescribers use of certain antibiotics.
This year we have looked at the use of quinolones, 
ketasporines and Co-amoxiclav… influenced by the 
national agenda but also our local medicines manage-
ment team at the CCG, they push that agenda as one 
of their priorities for the year and resource it through 
the prescribing incentive scheme. So inevitably there 
were rewards available to practices and practitioners, 
so that will influence my prescribing for sure. (I21P)
Auditing the prescription of antibiotics by manage-
ment teams and benchmarking against peers had a posi-
tive influence on prescribing practice and was viewed as 
necessary.
So over in Bath and Somerset, that is what they (med-
icines management team) has been doing, so if you 
are over prescribing, against your peers, you are iden-
tified and you are invited to come down for a training 
day. It is a little bit heavy handed, but we are heading 
towards a very scary place and I think we need to be 
quite bold with our interventions. (I2N)
Emotion (automatic motivation)
Antibiotics were sometimes prescribed to manage 
patients when explanations for a no-antibiotic decision 
had failed. Empathy for unwell patients could also make 
a no prescribing decision difficult. The time of day, day 
of the week, feeling stressed and tired also influenced 
prescribing, prescribers, in these instances, being less 
conservative in their use of antibiotics.
… [T]owards the end of the day, I am a little bit more 
lenient, because you are tired and a bit stressed and 
you want to go home, and sometimes it can be an easy 
fix. I try not to, but sometimes, whether at the be-
ginning of the day you weren’t quite sure, you would 
rationalise it a bit more and explain it a bit more, 
whereas you might at the end of the day, you might 
sort of lean to like well I am not quite sure, ok just 
take them. (I12N)
Environmental context and resources (physical opportunity)
Participants described how they used an array of acces-
sible resources, including tailored and locally relevant 
information, local and national guidelines, point-of-care 
testing, decision support tools and information about 
patients (including comorbidities, previous antibiotic 
use and frequency of return visits), to inform treatment 
decisions and to communicate decisions to their patients. 
Time pressures was reported by some prescribers to 
impact negatively on prescribing. Many acknowledged 
that having longer appointment times (15 min) than GPs, 
facilitated patient education and discussions about treat-
ment decisions.
… so the GPs get 10 min… myself and some of 
the Nurse Practitioners that I work with … in our 
practice have 15… after a few years of experience, we 
kind of can do a respiratory tract infection consulta-
tion in 10 min… you can do it, so you still have that 
extra sort of like two to three, 4 min… Which we can 
spend on educating the patient. (I7P)
Time and resources to follow-up patients, encouraging 
patients to return if symptoms did not improve and the 
ability to allow patients to contact them quickly were high-
lighted as important by some prescribers. Patient features, 
such as age, influenced the ease with which it was possible 
to manage RTIs without antibiotics, with technological 
literacy cited as being helpful here. Language barriers 
were also reported to be a problem while maintaining 
appropriate prescribing.
Social influences (social opportunity)
A range of strategies, including reassurance, education 
(including information on symptoms, length of time to get 
better, self-management and red flags) and active patient 
engagement in decision making were used to manage 
patients’ expectations. Patients pressure for an antibiotic 
was described as a key challenge and strategies to manage 
this included delayed prescribing, patient education and 
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consistency in antibiotic use. Public awareness campaigns 
and environmental prompts were also helpful. Good 
rapport and a trusting relationship were important 
when communicating a ‘no prescribing’ decision. Most 
prescribers discussed the role of other prescribers in 
influencing their prescribing decisions, including the 
role of social and collaborative networks. Collaborative 
working helped avoid situations whereby patients try to 
obtain an antibiotic from a different prescriber and reas-
sured prescribers that they were consistent in their deci-
sion making. However, such working occasionally led to 
problems, especially when disputes about the appropri-
ateness of antibiotics arose and the other prescriber was 
a clinician.
People (another prescriber) will say, just give them 
another one (different type of antibiotic), and I will 
think that’s not really what I am asking you, I just 
wanted to discuss it and see if we can do something 
else, because I am not really sure if it is going to do 
anything if I do take you know (different type of anti-
biotic)… But then you are arguing with another clini-
cian and maybe that is a doctor versus another nurse 
practitioner, so there is a slightly different playing 
field there. So yes those are some of the things (that 
influence prescribing). (I3N)
Identification of bCts
Forty naturally occurring BCTs (see online supplementary 
table 1) were identified as used by nurse and pharmacist 
prescribers when the target behaviour (ie, appropriate 
antibiotic prescribing) is facilitated. Two or more of these 
BCTs were coded within each TDF domain (see table 3).
BCTs that occurred frequently across domains included 
‘Instruction on how to perform the behaviour’ (infor-
mation on current guidelines and knowledge of patient 
self-management), ‘self monitoring of behaviour’ (high-
lighting own prescribing behaviour), ‘feedback on 
behaviour’ (the use of audit to scrutinise prescribing 
practice), social comparison (comparison of behaviour 
to peers), ‘information about health consequences’ 
(consequences of AMR), ‘demonstration of behaviour’ 
(physical examination skills and no antibiotic prescribing 
behaviour), ‘problem solving’ (patient engagement in 
decision making) and ‘goal setting’ (reduce prescribing 
rate). These are therefore prime BCTs to use for future 
intervention.
DIsCussIOn
statement of principal findings
To our knowledge, this is the first study to use a theoret-
ical framework to identify the factors that influence the 
antibiotic prescribing behaviour for RTIs, by nurse and 
pharmacist prescribers, and examine how this might 
inform the development of an intervention to support 
appropriate prescribing behaviour. Twelve TDF domains 
were found to influence the management of RTIs by 
these prescribers based on initial inductive analysis, and 
40 naturally occurring BCTs were identified to facilitate 
the behaviour.
strengths and weaknesses
By using the TDF and the BCTTv1, we have identified 
core ingredients that can be used in interventions to 
support appropriate antibiotic prescribing by NMPs. A 
further key strength is that participants were a national 
sample. However, few were pharmacists, and most 
worked in general practice. The findings may therefore 
Table 3 TDF domains and associated BCTs
Domain
BCTs suggested by nurse and pharmacist 
prescribers to support behaviour.
Knowledge Instruction on how to perform the behaviour.
Information about health consequences.
Social comparison.*
Feedback on behaviour.*
Credible source.
Skills Instruction on how to perform a behaviour.
Demonstration of the behaviour.
Social/professional 
role and identity
Identification of self as role model.
Social comparison.
Instruction on how to perform the behaviour.
Beliefs about 
capabilities
Focus on past success.*
Verbal persuasion about capability.
Mental rehearsal of successful performance.
Beliefs about 
consequences
Instruction on how to perform the behaviour.
Information about health consequences.
Information about social and environmental 
consequences.*
Demonstration of the behaviour.
Reinforcement Material reward (behaviour).
Monitoring behaviour by others without 
feedback.
Feedback on behaviour.
Goals Self-monitoring of behaviour.
Goal setting (behaviour).*
Review behaviour goal(s).
Memory, attention 
and decision 
processes
Problem solving.
Instruction on how to perform the behaviour.
Environmental 
context and 
resources
Instruction on how to perform the behaviour.
Prompts and cues.*
Problem solving.
Social influences Social support (unspecified).*
Problem solving.
Social comparison.
Restructuring the social environment.
Goal setting (behaviour).
Information about health consequences.
Emotion Reduce negative emotions.*
Information about emotional consequences.
Monitoring of emotional consequences.
Behavioural 
regulation
Self-monitoring of behaviour.*
Feedback on behaviour.
Social comparison.
*BCT and associated TDF domains also identified by Cane et al.48
BCTs, behaviour change techniques; TDF, Theoretical Domains 
Framework.
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represent the views of nurses working in general practice. 
However, this picture reflects UK primary care where 
most prescribers are nurses24 with high numbers working 
in general practice.34
Interviews were undertaken iteratively, with no new 
data relevant to the topic of interest generated in the 
latter interviews, suggesting data saturation. We did not 
use random sampling. Participants were an opportunistic 
sample and therefore may have been more motivated 
towards appropriate antibiotic prescribing. Less moti-
vated prescribers may have additional deterrents. Hence, 
the identification of BCTs within the domain of ‘motiva-
tion’ may overestimate the occurence of these features in 
the wider prescribing population.
Comparison with other studies
Our findings have identified that a broad range of factors 
influence the prescribing behaviour of nurse and phar-
macist prescribers. The limited evidence available has 
identified some of these influences. Similar to findings 
reported previously,23 37 we found that relationships with 
other prescribers and knowledge of current guidelines 
influenced behaviour. Diagnostic uncertainty and the 
clinical condition of the patient, influences we identified, 
have also been reported.23 38 39 As in our research, patient 
expectations for an antibiotic have also been cited.23 39 
Interestingly, prescribers in our study reported that they 
saw patient expectations for an antibiotic as an an oppor-
tunity to educate patients and that having additional time 
enabled them to capitablise on this teachable moment.40
The TDF has been used to examine the antibiotic 
prescribing behaviour of doctors working in long-term 
care facilities41 and dental practitioners.42 Studies have 
also explored GPs’ adherence to high-impact indicators 
including avoidance of risky prescribing,43 GP prescribing 
for older patients in primary care44 and inappropriate 
prescribing by hospital doctors.45 As in our research, a 
broad range of determinants were identified by each study. 
However, we are unaware of any research that has used 
the TDF to explore GPs antibiotic prescribing behaviour. 
Influencing factors identified by studies that are available 
can broadly be categorised into five domains including 
social influences (patient expectations12 and pressure 
for an antibiotic13 46), beliefs about consequences (diag-
nostic complexity,47 prognostic uncertainty14 and fear 
of complications14), knowledge (lack of consistent treat-
ment guidelines15), beliefs about capability (self-belief 
in decision making15) and environmental context and 
resources (time pressures15). Although these factors also 
influenced NMPs prescribing decisions, a further seven 
domains in the TDF (skills, social professional role and 
identity, reinforcement, goals, memory, attention and 
decision making, emotion and behaviour regulation) 
unique to NMPs were identified as important determi-
nants of behaviour. Furthermore, within these domains, 
NMPs used various strategies to overcome perceived 
barriers to inappropriate prescribing.
Our findings are in-line with expert consensus work48 
that has mapped BCTs to TDF domains for which they 
are most likely to be effective. Nine of the BCTs we 
identified were associated with 7 TDF domains and 
this supports the associations described by Cane et al43 
(see table 3). Furthermore, a review of interventions, 
designed to increase public antimicrobial awareness 
and/or to improve AMS,49 identified, as in our research, 
commonly used individual BCTs associated with the TDF 
domain. Knowledge were ‘Information about health 
consequences’ and ‘Instruction on how to perform a 
behaviour’. ‘Prompts and cues’ were similarly associated 
with the domain ‘Environmental Context and Resources’. 
‘Monitoring of behaviour without feedback’ and ‘Feed-
back on behaviour’, also BCTs identified as important in 
our research, were reported by these researchers to be 
unique to the most successful interventions.
Meaning of the study: possible explanations and implications 
for clinicians and policy makers
Our findings can be used as the basis for development 
of a theoretically informed intervention to support 
appropriate prescribing by nurse and pharmacist 
prescribers. They can also be used by practitioners to 
identify their individual facilitators and barriers to appro-
priate prescribing. Numerous intervention are available 
that target the antibiotic prescribing behaviour of GPs. 
Although these interventions could potentially target 
some of the drivers of behaviour among NMPs, they are 
unlikely to target all of these drivers. Future interventions 
should target the seven domains unique to NMPs that this 
study has identified.
unanswered questions and future research
The next step is to develop an intervention based on our 
findings and test its feasibility and acceptability among 
nurse and pharmacist prescribers and whether it results 
in lasting changes to antibiotic prescribing behaviours.
COnClusIOn
Given that increasing numbers of NMPs working in 
primary care and managing infections, it is important that 
these findings are used to inform theoretically grounded 
interventions to support appropriate prescribing 
behaviour by these groups.
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